Your browser doesn't support javascript.
loading
Therapeutic Benefits of Melatonin against COVID-19.
Mubashshir, Muhammad; Ahmad, Nabeel; Negi, Tripti; Rawal, Renu; Singhvi, Nirjara; Khatoon, Hina; Laxmi, Vijya; Dubey, Om; Sharma, Renu Bala; Negi, Ganga; Ovais, Mohd.
Afiliación
  • Mubashshir M; School of Allied Sciences, Dev Bhoomi Uttarakhand University, Dehradun, India.
  • Ahmad N; School of Allied Sciences, Dev Bhoomi Uttarakhand University, Dehradun, India.
  • Negi T; School of Allied Sciences, Dev Bhoomi Uttarakhand University, Dehradun, India.
  • Rawal R; School of Allied Sciences, Dev Bhoomi Uttarakhand University, Dehradun, India.
  • Singhvi N; School of Allied Sciences, Dev Bhoomi Uttarakhand University, Dehradun, India.
  • Khatoon H; School of Allied Sciences, Dev Bhoomi Uttarakhand University, Dehradun, India.
  • Laxmi V; School of Allied Sciences, Dev Bhoomi Uttarakhand University, Dehradun, India.
  • Dubey O; School of Allied Sciences, Dev Bhoomi Uttarakhand University, Dehradun, India.
  • Sharma RB; School of Allied Sciences, Dev Bhoomi Uttarakhand University, Dehradun, India.
  • Negi G; School of Allied Sciences, Dev Bhoomi Uttarakhand University, Dehradun, India.
  • Ovais M; Department of Bio-Science, Barkatullah University, Bhopal, India.
Neuroimmunomodulation ; 30(1): 196-205, 2023.
Article en En | MEDLINE | ID: mdl-37336193

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 / Melatonina Tipo de estudio: Guideline Límite: Child / Humans Idioma: En Revista: Neuroimmunomodulation Asunto de la revista: ALERGIA E IMUNOLOGIA / NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 / Melatonina Tipo de estudio: Guideline Límite: Child / Humans Idioma: En Revista: Neuroimmunomodulation Asunto de la revista: ALERGIA E IMUNOLOGIA / NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: India